Access the full text.
Sign up today, get DeepDyve free for 14 days.
Guyton (1987)
Emergency coronary bypass for cardiogenic shockCirculation, 76
Ziljstra (1993)
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarctionN Engl J Med, 328
Carnendran (2001)
Trends in cardiogenic shock: Report from the SHOCK StudyEur Heart J, 22
Antman (1999)
Abciximab facilitates the rate and extent of thrombolysis: Results of TIMI-14 trialCirculation
Brouwer (1995)
Adverse long-term effects of reocclusion after coronary thrombolysisJ Am Coll Cardiol, 26
Vermeer (1999)
Prospective randomised comparsion between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: A safety and feasibility studyHeart, 82
Moosvi (1992)
Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarctionJ Am Coll Cardiol, 19
Zahn (2001)
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: Can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Ttherapy in Aacute Myocardial Infarction Registry and the Myocardial Infarction RegistryJ Am Coll Cardiol, 37
GUSTO-III Investigators (1997)
A comparison of reteplase with alteplase for acute myocardial infarctionN Engl J Med, 337
Simes (1995)
for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusionCirculation, 91
Grines (1993)
A comparison of immediate angiolasty with thrombolytic therapy for acute myocardial infarctionN Engl J Med, 328
Dunkman (1972)
Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shockCirculation, 46
Bode (1996)
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarctionCirculation, 94
Vermeer (1997)
Safety and feasibility of rescue PTCA or primary PTCA in patients with acute myocardial infarction admitted to a hospital without PTCA facilitiesJ Am Coll Cardiol, 29
Berger (1999)
Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarctionCirculation, 100
Hochman (1995)
Current spectrum of cardiogenic shock and effect of early revascularization on mortality: Results of an international registryCirculation, 91
Ziljistra (1997)
Transferring patients for primary angioplasty: A retrospective analysis of 104 selected high risk patients with acute myocardial infarctionHeart, 78
Widimsky (1998)
Transport for primary PTCA: Results of the pilot phase of the PRAGUE Study-national multicenter randomized study on patients with acute myocardial infarction presenting to community hospitals [abstract]Circulation, 98(suppl)
The GUSTO-V Investigators (2001)
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO-V randomised trialLancet, 357
Cannon (1994)
Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplace and combination thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trialJ Am Coll Cardiol, 24
Himbert (1994)
Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarctionAm J Cardiol, 74
Brodie (1994)
Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final result from the Primary Angioplasty RegistryCirculation, 25
The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators (2001)
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarctionLancet, 358
Brodie (1998)
Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarctionJ Am Coll Cardiol, 32
Goldberg (1991)
Cardiogenic shock after acute myocardial infarction: Incidence and mortality from a community wide perspective 1975-1988N Engl J Med, 325
Gibbons (1993)
Immediate angioplasty compared with the administration of a thrombolytic agent followed by a conservative treatment for myocardial infarctionN Engl J Med, 328
Bengtson (1992)
Prognosis in cardiogenic shock after acute myocardial infarction in the interventional eraJ Am Coll Cardiol, 20
Gore (1989)
Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarctionArch Intern Med, 149
Straumann (1999)
Hospital transfer for primary coronary angioplasty in high risk patients with acute myocardial infarctionHeart, 82
Holmes (1995)
Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experienceJ Am Coll Cardiol, 26
Killip (1967)
Treatment of myocardial infarction in a coronary care unit. A two experience with 250 patientsAm J Cardiol, 20
Verheught (1996)
Reocclusion: The flip side of coronary thrombosisJ Am Coll Cardiol, 27
GUSTO IIb Angioplasty Substudy Investigators (1997)
A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarctionN Engl J Med, 336
Second International Study of Infarct Survival Collaborative Group (1988)
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2Lancet
Widimsky (2000)
for the PRAGUE Study. Multicenter randomized trial comparing transport to primary angioplasty versus immediate thrombolysis versus combined strategy for patients with acute myocardial infarction presenting to a community hospital without catheterization laboratoryEur Heart J, 21
Hochman (1999)
for the SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shockN Engl J Med, 341
Barbagelata (1997)
TIMI grade 3 flow and reoclusion after intravenous thrombolytic therapy: A pooled analysisAm Heart J, 133
Lee (1988)
Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shockCirculation, 78
Bellinger (1988)
Helicopter transport of patients during acute myocardial infarctionAm J Cardiol, 61
GUSTO Angiographic Investigators (1993)
The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular fuction, and survival after myocardial infarctionN Engl J Med, 329
Hibbard (1992)
Percutaneous transluminal coronary angioplasty in patients with cardiogenic shockJ Am Coll Cardiol, 19
Liem (1998)
van't Hof AWJ, Hoorntje JCA, et al. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplastyJ Am Coll Cardiol, 32
Grines (1996)
Primary angioplasty: The strategy of choiceN Engl J Med, 335
Hochman (1999)
Effects of early revascularization for cardiogenic shock on 1 year mortality: The SHOCK trial resultsCirculation, 100
Objective: The objective of this study is to assess the feasibility and safety of interhospital transfer (within up to 60 minutes) for primary/rescue coronary angioplasty of patients with myocardial infarction (AMI) complicated by an early onset of acute heart failure (AHF) admitted to a community hospital without PCI facilities. Design and patients: From the multicenter randomized PRAGUE‐1 study, a subgroup of 66 patients with AMI complicated by AHF on the first presentation to the community hospital were retrospectively analyzed. Group A patients (n = 21) were treated on site in community hospitals using thrombolysis (streptokinase), group B patients (n = 20) were transported with thrombolytic infusion to a PCI center for coronary angioplasty, and group C patients (n = 25) were immediately transported to a PCI center for primary angioplasty without thrombolysis. Results: No patient died during transportation. One group B patient developed ventricular fibrillation during transfer. The time delay from the onset of chest pain to reperfusion was >142 minutes, and 253 and 251 minutes in groups A, B, and C, respectively. Hospital stay (16 vs 11 vs 10 days, P = NS ) was shorter in the angioplasty groups. Transported patients (groups B, C) displayed a significant decrease in heart failure progression within the first 24 hours after treatment (48% vs 15% vs 8%, P < 0.05 ). The combined end point, i.e., mortality + nonfatal reinfarction (43% vs 25% vs 8%, P < 0.05 ), was significantly less frequent in the coronary angioplasty group. Conclusions: Interhospital transfer for coronary angioplasty of patients with AMI complicated by an early onset of AHF is feasible and safe. Transport for angioplasty may even reduce the risk of heart failure progression and improve clinical outcome compared to immediate thrombolysis in the nearest community hospital. (J Interven Cardiol 2003;16:201–208)
Journal of Interventional Cardiology – Wiley
Published: Jun 1, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.